Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial

Autor: Schoof, N. *, von Bonin, F., Zeynalova, S., Ziepert, M., Jung, W., Loeffler, M., Pfreundschuh, M., Trümper, L., Kube, D.
Zdroj: In Annals of Oncology September 2009 20(9):1548-1554
Databáze: ScienceDirect